AZD-5423 - AZD-5423

AZD-5423

Identifikatorlar
IUPAC nomi 2,2,2-Trifloro-N-[(1R,2S) -1 - {[1- (4-florofenil) -1H-indazol-5-il] oksi} -1- (3-metoksifenil) -2-propanil] asetamid
CAS raqami	1034148-04-3 Y
PubChem CID	24825740
ChemSpider	28536140
UNII	641H0Q518W
CompTox boshqaruv paneli (EPA)	DTXSID40145823
ECHA ma'lumot kartasi	100.205.965
Kimyoviy va fizik ma'lumotlar
Formula	C25H21F4N3O3
Molyar massa	487.455 g · mol−1
3D model (JSmol )	Interaktiv rasm
Jilmayganlar C [C @@ H] ([C @@ H] (c1cccc (c1) OC) Oc2ccc3c (c2) cnn3c4ccc (cc4) F) bosimining ko'tarilishi (= O) C (F) (F) F
InChI InChI = 1S / C25H21F4N3O3 / c1-15 (31-24 (33) 25 (27,28) 29) 23 (16-4-3-5-20 (12-16) 34-2) 35-21-10- 11-22-17 (13-21) 14-30-32 (22) 19-8-6-18 (26) 7-9-19 / h3-15,23H, 1-2H3, (H, 31,33) ) / t15-, 23- / m0 / s1 Kalit: FCNQMDSJHADDFT-WNSKOXEYSA-N

AZD-5423 a steroid bo'lmagan glyukokortikoid va II bosqich eksperimental dori tomonidan ishlab chiqilmoqda AstraZeneca va 2013 yil bahorida oshkor qilingan Amerika kimyo jamiyati nafas olish yo'llari kasalliklarini davolash uchun Yangi Orleandagi uchrashuv va surunkali obstruktiv o'pka kasalligi.^{[1][2][3][4][5]}

Shuningdek qarang

• Dagrokorat
• Fosdagrokorat
• Mapracorat

Adabiyotlar

Tashqi havolalar

• AZD-5423 - AdisInsight

Bu dori ga tegishli maqola nafas olish tizimi a naycha. Siz Vikipediyaga yordam berishingiz mumkin uni kengaytirish.